US4671958A
(en)
|
1982-03-09 |
1987-06-09 |
Cytogen Corporation |
Antibody conjugates for the delivery of compounds to target sites
|
AU599373B2
(en)
|
1986-03-13 |
1990-07-19 |
Biotechnology Australia Proprietary Limited |
Method of assay of inhibin
|
US4801575A
(en)
|
1986-07-30 |
1989-01-31 |
The Regents Of The University Of California |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
US4902505A
(en)
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
US4904768A
(en)
|
1987-08-04 |
1990-02-27 |
Bristol-Myers Company |
Epipodophyllotoxin glucoside 4'-phosphate derivatives
|
GB2208511A
(en)
|
1987-08-07 |
1989-04-05 |
Bayer Ag |
Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
|
US4942184A
(en)
|
1988-03-07 |
1990-07-17 |
The United States Of America As Represented By The Department Of Health And Human Services |
Water soluble, antineoplastic derivatives of taxol
|
US5632990A
(en)
|
1988-04-22 |
1997-05-27 |
Cancer Research Campaign Tech. Ltd. |
Treatment for tumors comprising conjugated antibody A5B7 and a prodrug
|
US5258499A
(en)
|
1988-05-16 |
1993-11-02 |
Vestar, Inc. |
Liposome targeting using receptor specific ligands
|
US5028697A
(en)
|
1988-08-08 |
1991-07-02 |
Eli Lilly And Company |
Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers
|
US5169933A
(en)
|
1988-08-15 |
1992-12-08 |
Neorx Corporation |
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
US5948634A
(en)
|
1988-12-21 |
1999-09-07 |
The General Hospital Coporation |
Neural thread protein gene expression and detection of alzheimer's disease
|
DE3912638A1
(de)
|
1989-04-18 |
1990-10-31 |
Bayer Ag |
Gentechnologisch hergestellte homologe des alzheimer protease inhibitors, wirtstaemme sowie expressionsvektoren fuer ihre herstellung und ihre verwendung als arzneimittel
|
US5126249A
(en)
|
1989-05-09 |
1992-06-30 |
Eli Lilly And Company |
Enzymatic removal of a protein amino-terminal sequence
|
US6020145A
(en)
|
1989-06-30 |
2000-02-01 |
Bristol-Myers Squibb Company |
Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
|
US6475781B1
(en)
|
1990-05-17 |
2002-11-05 |
Dana-Farber Cancer Institute, Inc. |
Trans-dominant suppressor genes for oligomeric proteins
|
GB9017008D0
(en)
|
1990-08-02 |
1990-09-19 |
Erba Carlo Spa |
Process for the enzymatic preparation of basic fibroblast growth factor
|
US5714167A
(en)
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US6495513B1
(en)
|
1991-03-11 |
2002-12-17 |
Curis, Inc. |
Morphogen-enhanced survival and repair of neural cells
|
US5955444A
(en)
|
1991-08-09 |
1999-09-21 |
Massachusetts Institute Of Technology |
Method of inhibiting abnormal tau hyper phosphorylation in a cell
|
US5627270A
(en)
|
1991-12-13 |
1997-05-06 |
Trustees Of Princeton University |
Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
|
US5204354A
(en)
|
1992-02-14 |
1993-04-20 |
Merck & Co., Inc. |
Substituted quinazolinones as neurotensin antagonists useful in the treatment of CNS disorders
|
GB9213077D0
(en)
|
1992-06-19 |
1992-08-05 |
Erba Carlo Spa |
Polymerbound taxol derivatives
|
CA2145517A1
(fr)
|
1992-09-25 |
1994-04-14 |
Ignace Lasters |
Inhibiteurs du complexe facteur viia-facteur tissulaire derives de l'inhibiteur de la trypsine pancreatique bovine
|
JPH06228199A
(ja)
*
|
1992-11-27 |
1994-08-16 |
Takeda Chem Ind Ltd |
血液脳関門通過可能なペプチド結合体
|
EP0599303A3
(fr)
*
|
1992-11-27 |
1998-07-29 |
Takeda Chemical Industries, Ltd. |
Conjugués peptidiques
|
WO1994019692A1
(fr)
|
1993-02-18 |
1994-09-01 |
The General Hospital Corporation |
Substance therapeutique destinee a la maladie d'alzheimer
|
EP0820466A2
(fr)
|
1995-04-04 |
1998-01-28 |
Advanced Bioconcept Inc. |
Peptides fluorescent
|
WO1996035788A2
(fr)
|
1995-05-08 |
1996-11-14 |
Scios, Inc. |
Peptides inhibiteurs de proteases de type kunitz
|
ZA963619B
(en)
|
1995-05-08 |
1996-11-22 |
Scios Inc |
Protease inhibitor peptides
|
AU5908296A
(en)
|
1995-05-31 |
1996-12-24 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for targeted delivery of effector m olecules
|
US5780265A
(en)
|
1995-06-05 |
1998-07-14 |
Genentech, Inc. |
Kunitz type plasma kallikrein inhibitors
|
US5665702A
(en)
|
1995-06-06 |
1997-09-09 |
Biomeasure Incorporated |
Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
|
EP0831880A4
(fr)
|
1995-06-07 |
2004-12-01 |
Imclone Systems Inc |
Anticorps et fragments d'anticorps inhibant la croissance des tumeurs
|
DE69735996T2
(de)
|
1996-03-11 |
2007-02-15 |
Bayer Corp. |
Menschlicher bikunin
|
CA2252706A1
(fr)
|
1996-05-01 |
1997-11-06 |
Antivirals Inc. |
Conjugues polypeptidiques destines au transport de substances a travers des membranes cellulaires
|
DE19636889A1
(de)
|
1996-09-11 |
1998-03-12 |
Felix Dr Kratz |
Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel
|
WO1998016201A1
(fr)
|
1996-10-11 |
1998-04-23 |
Sequus Pharmaceuticals, Inc. |
Composition de liposomes therapeutiques et procede
|
US6056973A
(en)
|
1996-10-11 |
2000-05-02 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method of preparation
|
US5948750A
(en)
|
1996-10-30 |
1999-09-07 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
EP0975792B1
(fr)
|
1997-03-04 |
2007-10-10 |
Savient Pharmaceuticals, Inc. |
Isolement de ligands peptidiques a specificite tissulaire et utilisation de ces derniers pour cibler des substances pharmaceutiques sur des organes
|
GB9705903D0
(en)
|
1997-03-21 |
1997-05-07 |
Elliott Gillian D |
VP22 Proteins and uses thereof
|
US6126965A
(en)
|
1997-03-21 |
2000-10-03 |
Georgetown University School Of Medicine |
Liposomes containing oligonucleotides
|
PL337033A1
(en)
|
1997-05-21 |
2000-07-31 |
Univ Leland Stanford Junior |
Composition for and methods of enhancing transport through permeable biological membranes
|
US6391305B1
(en)
|
1997-09-10 |
2002-05-21 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
US6093692A
(en)
|
1997-09-25 |
2000-07-25 |
The University Of Southern California |
Method and compositions for lipidization of hydrophilic molecules
|
US6475481B2
(en)
|
1997-11-18 |
2002-11-05 |
Canji Inc |
Purging of stem cell products
|
WO1999026657A1
(fr)
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibiteurs de la monoxyde d'azote-synthase
|
US5981564A
(en)
|
1998-07-01 |
1999-11-09 |
Universite Laval |
Water-soluble derivatives of paclitaxel, method for producing same and uses thereof
|
GB9814527D0
(en)
|
1998-07-03 |
1998-09-02 |
Cyclacel Ltd |
Delivery system
|
US6703381B1
(en)
|
1998-08-14 |
2004-03-09 |
Nobex Corporation |
Methods for delivery therapeutic compounds across the blood-brain barrier
|
US5922754A
(en)
|
1998-10-02 |
1999-07-13 |
Abbott Laboratories |
Pharmaceutical compositions containing paclitaxel
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
AU768027B2
(en)
|
1999-02-24 |
2003-11-27 |
Uab Research Foundation, The |
Taxane derivatives for targeted therapy of cancer
|
US6329336B1
(en)
*
|
1999-05-17 |
2001-12-11 |
Conjuchem, Inc. |
Long lasting insulinotropic peptides
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
US6180607B1
(en)
|
1999-08-05 |
2001-01-30 |
Christopher Davies |
Protein having proteinase inhibitor activity
|
US6713454B1
(en)
|
1999-09-13 |
2004-03-30 |
Nobex Corporation |
Prodrugs of etoposide and etoposide analogs
|
WO2001021584A1
(fr)
|
1999-09-24 |
2001-03-29 |
Genentech, Inc. |
Derives de tyrosine
|
US6136846A
(en)
|
1999-10-25 |
2000-10-24 |
Supergen, Inc. |
Formulation for paclitaxel
|
DE19953696A1
(de)
|
1999-11-09 |
2001-05-10 |
Alexander Cherkasky |
Selektive proteolytische Synzyme (SPS)
|
CA2355334A1
(fr)
|
2000-10-16 |
2002-04-16 |
Procyon Biopharma Inc. |
Preparations pharmaceutiques et methodes visant a inhiber la croissance de tumeurs
|
WO2002043765A2
(fr)
|
2000-11-28 |
2002-06-06 |
Transform Pharmaceuticals, Inc. |
Formulations pharmaceutiques contenant du paclitaxel, ses derives et ses sels pharmaceutiquement acceptables
|
PL393178A1
(pl)
|
2000-12-07 |
2011-02-14 |
Eli Lilly And Company |
Heterogenne białko fuzyjne, kompozycja farmaceutyczna do leczenia pacjentów z cukrzycą insulino-niezależną i kompozycja farmaceutyczna do leczenia pacjentów z otyłością
|
EP1383492A4
(fr)
|
2001-03-23 |
2008-12-24 |
Napro Biotherapeutics Inc |
Conjugues moleculaires destines a etre utilises dans le traitement du cancer
|
EP2322631B1
(fr)
|
2001-04-19 |
2014-11-12 |
The Scripps Research Institute |
Procédés et composition pour la production de paires d'aminoacyl-ARN-T synthétase orthogonales
|
WO2003102583A1
(fr)
|
2002-05-29 |
2003-12-11 |
Symbiontics, Inc. |
Proteines therapeutiques ciblees
|
US20030170891A1
(en)
|
2001-06-06 |
2003-09-11 |
Mcswiggen James A. |
RNA interference mediated inhibition of epidermal growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
WO2003009815A2
(fr)
|
2001-07-25 |
2003-02-06 |
Biomarin Pharmaceutical Inc. |
Compositions et procedes de modulation du transport a travers la barriere hematho-encephalique
|
US20040161776A1
(en)
|
2001-10-23 |
2004-08-19 |
Maddon Paul J. |
PSMA formulations and uses thereof
|
US7192921B2
(en)
|
2001-11-08 |
2007-03-20 |
The Burnham Institute |
Peptides that home to tumor lymphatic vasculature and methods of using same
|
US20040058865A1
(en)
*
|
2001-11-26 |
2004-03-25 |
Danishefsky Samuel J |
Homing peptide multimers, their preparation and uses
|
EP1472351B1
(fr)
|
2002-02-07 |
2007-06-20 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Sequences d'acides amines facilitant la penetration a travers une barriere biologique
|
US7101844B2
(en)
|
2002-03-29 |
2006-09-05 |
Creagene, Inc. |
Cytoplasmic transduction peptides and uses thereof
|
US6881829B2
(en)
|
2002-04-26 |
2005-04-19 |
Chimeracom, L.L.C. |
Chimeric hybrid analgesics
|
WO2004003145A2
(fr)
|
2002-06-28 |
2004-01-08 |
Nastech Pharmaceutical Company Inc. |
Compositions et methodes permettant de moduler la physiologie de molecules d'adhesion jonctionnelle epitheliale en vue d'ameliorer l'administration de composes therapeutiques par voie muqueuse
|
EP2305812A3
(fr)
|
2002-11-14 |
2012-06-06 |
Dharmacon, Inc. |
SIRNA fonctionnel et hyperfonctionnel
|
US7829694B2
(en)
|
2002-11-26 |
2010-11-09 |
Medtronic, Inc. |
Treatment of neurodegenerative disease through intracranial delivery of siRNA
|
US20040102369A1
(en)
|
2002-11-27 |
2004-05-27 |
The Regents Of The University Of California |
Transport of basic fibroblast growth factor across the blood brain barrier
|
US7388079B2
(en)
|
2002-11-27 |
2008-06-17 |
The Regents Of The University Of California |
Delivery of pharmaceutical agents via the human insulin receptor
|
US7319090B2
(en)
|
2002-11-27 |
2008-01-15 |
University Of North Carolina At Chapel Hill |
Methods of treating cerebral ischemia
|
CN102775472A
(zh)
|
2003-01-06 |
2012-11-14 |
安吉奥开米公司 |
作为穿过血脑屏障的载体的抑酶肽及类似物
|
US20040162284A1
(en)
|
2003-02-19 |
2004-08-19 |
Harris Herbert W. |
Method of lowering body temperature with (S) tofisopam
|
DK2368553T3
(en)
|
2003-04-08 |
2015-02-09 |
Progenics Pharm Inc |
Pharmaceutical preparation comprising methylnaltrexone
|
JP4848267B2
(ja)
|
2003-04-08 |
2011-12-28 |
バイオテンプト、ビー.ヴイ. |
Hcg断片を含む粘膜及び経口投与のための組成物
|
EP1620544B1
(fr)
|
2003-04-17 |
2018-09-19 |
Alnylam Pharmaceuticals Inc. |
Agents modifies d'arni
|
WO2004108071A2
(fr)
|
2003-06-05 |
2004-12-16 |
Salk Institute For Biological Studies |
Compositions et methodes destinees a cibler un polypeptide sur le systeme nerveux central
|
US20050026823A1
(en)
|
2003-06-20 |
2005-02-03 |
Biomarin Pharmaceutical Inc. |
Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues
|
JP5624256B2
(ja)
|
2003-06-20 |
2014-11-12 |
ラプター・ファーマシューティカル・インコーポレイテッド |
脳および他の組織への治療化合物の送達
|
CN100457775C
(zh)
|
2003-08-08 |
2009-02-04 |
普洛图斯科学株式会社 |
具有脑定位活性的多肽及其用途
|
US20070275871A1
(en)
|
2003-08-28 |
2007-11-29 |
Biorexis Technology, Inc. |
Epo Mimetic Peptides and Fusion Proteins
|
US20050058702A1
(en)
|
2003-09-17 |
2005-03-17 |
Ben-Sasson Shmuel A. |
Compositions capable of facilitating penetration across a biological barrier
|
US20050208095A1
(en)
|
2003-11-20 |
2005-09-22 |
Angiotech International Ag |
Polymer compositions and methods for their use
|
US7208174B2
(en)
|
2003-12-18 |
2007-04-24 |
Hoffmann-La Roche Inc. |
Liposome compositions
|
AU2005327906B2
(en)
|
2004-07-21 |
2010-05-13 |
Ambrx, Inc. |
Biosynthetic polypeptides utilizing non-naturally encoded amino acids
|
KR100891509B1
(ko)
|
2004-07-26 |
2009-04-06 |
아스테리온 리미티드 |
연결체들
|
ATE439440T1
(de)
|
2004-09-29 |
2009-08-15 |
Childrens Memorial Hospital |
Sirna-vermitteltes gen-silencing von alpha- synuklein
|
US9002652B1
(en)
|
2005-01-27 |
2015-04-07 |
Institute For Systems Biology |
Methods for identifying and using organ-specific proteins in blood
|
ES2383901T5
(es)
|
2005-02-18 |
2015-02-25 |
Angiochem Inc. |
Polipéptidos de aprotinina para transportar un compuesto a través de la barrera sangre-cerebro
|
ATE531365T1
(de)
|
2005-02-18 |
2011-11-15 |
Abraxis Bioscience Llc |
Kombinationen und modi zur verabreichung therapeutischer mittel und kombinationstherapie
|
US20090016959A1
(en)
*
|
2005-02-18 |
2009-01-15 |
Richard Beliveau |
Delivery of antibodies to the central nervous system
|
WO2006108052A2
(fr)
|
2005-04-06 |
2006-10-12 |
Genzyme Corporation |
Ciblage de glycoproteines therapeutiques
|
AU2006247471A1
(en)
|
2005-05-12 |
2006-11-23 |
Tapestry Pharmaceuticals, Inc. |
Molecular constructs suitable for targeted conjugates
|
WO2006138343A2
(fr)
|
2005-06-14 |
2006-12-28 |
Raptor Pharmaceutical Inc. |
Compositions comprenant des variants de proteine associee au recepteur (rap) specifiques a lrp2, et utilisations correspondantes
|
PL2233156T3
(pl)
|
2005-07-15 |
2013-09-30 |
Angiochem Inc |
Zastosowanie polipeptydów aprotyninowych jako nośników w koniugatach farmaceutycznych
|
BRPI0615562A2
(pt)
|
2005-07-19 |
2010-01-26 |
Univ Illinois |
agentes de transporte para atravessamento da barreira sangue-cérebro e entrada nas células cancerìgenas do cérebro e métodos para o seu uso
|
GB0517092D0
(en)
|
2005-08-19 |
2005-09-28 |
Novartis Ag |
New compositions containing taxane derivatives
|
CA2621694A1
(fr)
|
2005-09-08 |
2007-03-15 |
Nastech Pharmaceutical Company Inc. |
Compositions pharmaceutiques pour acheminer de l'acide ribonucleique dans une cellule
|
WO2007035716A2
(fr)
|
2005-09-16 |
2007-03-29 |
Raptor Pharmaceutical Inc. |
Compositions de proteines rap specifiques des proteines contenant du cr, et leurs utilisations
|
US8142781B2
(en)
|
2005-10-07 |
2012-03-27 |
Armagen Technologies, Inc. |
Fusion proteins for blood-brain barrier delivery
|
US20070197460A1
(en)
|
2005-11-01 |
2007-08-23 |
Alnylam Pharmaceuticals, Inc. |
Rnai inhibition of influenza virus replication
|
WO2007053946A1
(fr)
|
2005-11-09 |
2007-05-18 |
Conjuchem Biotechnologies Inc. |
Procede de traitement du diabete et/ou de l'obesite en reduisant les effets secondaires nauseeux au moyen d'un peptide insulinotrope conjugue a de l'albumine
|
US8290433B2
(en)
|
2007-11-14 |
2012-10-16 |
Blaze Mobile, Inc. |
Method and system for securing transactions made through a mobile communication device
|
AR054215A1
(es)
|
2006-01-20 |
2007-06-13 |
Eriochem Sa |
Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
|
EP2863222A1
(fr)
*
|
2006-03-06 |
2015-04-22 |
Amunix Operating Inc. |
Polymères recombinants non structurés et leurs utilisations
|
US7477504B1
(en)
|
2006-03-13 |
2009-01-13 |
C.P.D. Technologies, Inc. |
Versatile stun glove
|
ES2484967T3
(es)
*
|
2006-03-30 |
2014-08-12 |
Glaxo Group Limited |
Anticuerpos contra el péptido beta-amiloide
|
CA2657649A1
(fr)
|
2006-07-13 |
2008-08-21 |
Burnham Institute For Medical Research |
Procedes et compositions de ciblage de la proteine gc1qr/p32
|
AU2007278994B2
(en)
|
2006-07-24 |
2013-08-15 |
Biorexis Pharmaceutical Corporation |
Exendin fusion proteins
|
CN101594878A
(zh)
|
2006-09-18 |
2009-12-02 |
雷普特药品公司 |
通过给予受体相关蛋白(rap)-缀合物对肝病症的治疗
|
CA2666841A1
(fr)
|
2006-10-19 |
2008-04-24 |
Angiochem, Inc. |
Composes destines a stimuler le fonctionnement de la p-glycoproteine et leurs utilisations
|
WO2008069876A2
(fr)
|
2006-10-27 |
2008-06-12 |
University Of Kentucky Research Foundation |
Peptides amides stimulant les neurones dopaminergiques pour la régulation dopaminergique à la hausse du système nerveux central
|
US9399675B2
(en)
|
2007-02-28 |
2016-07-26 |
The Board Of Regents Of The University Of Oklahoma |
Methods and compositions for diagnosing Alzheimer's disease and age-related macular degeneration
|
BRPI0809234A2
(pt)
|
2007-03-21 |
2014-09-02 |
Raptor Pharmaceutical Inc |
Peptídeos de proteína associada a receptor (rap) cíclico
|
CA2688344C
(fr)
|
2007-05-29 |
2019-09-03 |
Angiochem, Inc. |
Polypeptides de type aprotinine pour administrer a des tissus des agents conjugues a ceux-ci
|
US8802631B2
(en)
|
2007-09-17 |
2014-08-12 |
Ludwig Institute For Cancer Research Ltd. |
Peptides and methods for the treatment of gliomas and other cancers
|
CN101939027B
(zh)
|
2007-10-02 |
2014-07-30 |
玛瑞纳生物技术有限公司 |
用于递送核酸的脂肽
|
WO2009070597A2
(fr)
|
2007-11-26 |
2009-06-04 |
Armagen Technologies, Inc. |
Protéines de fusion assurant le transport du gdnf jusqu'au système nerveux central
|
MX2010006925A
(es)
*
|
2007-12-20 |
2011-05-02 |
Angiochem Inc |
Conjugados de polipeptido-acido nucleico y sus usos.
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
BRPI0907363A2
(pt)
|
2008-02-21 |
2015-08-18 |
Burnham Inst Medical Research |
Métodos e composições relativos a peptídeos e proteínas com elementos de c-terminal
|
ES2721148T3
(es)
|
2008-04-18 |
2019-07-29 |
Angiochem Inc |
Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel y métodos relacionados de preparación y uso
|
US20110117627A1
(en)
|
2008-07-10 |
2011-05-19 |
The Board Of Trustees Of The University Of Illinois |
Regulation of apoptosis by neural specific splice variants of ig20
|
EP2346896A4
(fr)
|
2008-10-15 |
2014-06-25 |
Angiochem Inc |
Conjugués de l'étoposide et de la doxorubicine pour l'administration de médicaments
|
EP2346906A4
(fr)
|
2008-10-15 |
2013-04-24 |
Angiochem Inc |
Conjugués d'agonistes de glp-1 et leurs utilisations
|
BRPI0922689A2
(pt)
|
2008-12-05 |
2018-11-06 |
Angiochem Inc. |
conjugados de neurotensina ou análogos de neurotensina e usos dos mesmos
|
JP2012510797A
(ja)
|
2008-12-05 |
2012-05-17 |
アンジオケム インコーポレーテッド |
レプチンおよびレプチン類似体コンジュゲートならびにそれらの使用
|
MX2011005964A
(es)
*
|
2008-12-05 |
2011-09-01 |
Angiochem Inc |
Conjugados terapeuticos de peptidos y sus usos.
|
JP2012512185A
(ja)
|
2008-12-17 |
2012-05-31 |
アンジオケム インコーポレーテッド |
膜1型マトリックス金属タンパク質阻害剤およびその使用
|
JP2012524030A
(ja)
|
2009-04-20 |
2012-10-11 |
アンジオケム インコーポレーテッド |
Angiopep−2アナログにコンジュゲート化した抗癌剤を用いた卵巣癌の治療
|
US20100284921A1
(en)
|
2009-05-08 |
2010-11-11 |
Temple University - Of The Commonwealth System Of Higher Education |
Targeted nanoparticles for intracellular cancer therapy
|
CN102753187A
(zh)
|
2009-06-03 |
2012-10-24 |
戴瑟纳制药公司 |
肽-dicer底物试剂及其特异性抑制基因表达的方法
|
AU2010258052A1
(en)
|
2009-06-11 |
2012-01-12 |
Angiochem Inc. |
Fusion proteins for delivery of GDNF and BDNF to the central nervous system
|
BRPI1015918A2
(pt)
|
2009-07-02 |
2019-09-24 |
Angiochem Inc |
conjugados de peptídeo multiméricos e usos dos mesmos
|
HUE026708T2
(en)
|
2009-07-14 |
2016-07-28 |
Mayo Foundation |
Peptide-mediated, non-covalent delivery of active substances in blood glucose
|
US20120277158A1
(en)
|
2009-10-06 |
2012-11-01 |
Angiochem Inc. |
Compositions and methods for the transport of therapeutic agents
|
US9095541B2
(en)
|
2009-11-24 |
2015-08-04 |
Arch Cancer Therapeutics, Inc. |
Brain tumor targeting peptides and methods
|
US8530429B2
(en)
|
2009-11-24 |
2013-09-10 |
Arch Cancer Therapeutics, Inc. |
Brain tumor targeting peptides and methods
|
EP2333074A1
(fr)
|
2009-12-14 |
2011-06-15 |
Robert Steinfeld |
Substances et procédés pour le traitement de maladies liées au stockage lysosomal
|
EA025443B1
(ru)
|
2010-03-08 |
2016-12-30 |
Слоан-Кеттеринг Институт Фор Кэнсер |
ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРА КИНАЗЫ Cdc7 ГРАНАТИЦИНА B
|
US9102697B2
(en)
|
2010-03-22 |
2015-08-11 |
President And Fellows Of Harvard College |
Trioxacarcins and uses thereof
|
WO2011119608A1
(fr)
|
2010-03-26 |
2011-09-29 |
University Of Tennessee Research Foundation |
Peptides qui ciblent spécifiquement les dépôts d'amyloïde
|
WO2011127580A1
(fr)
|
2010-04-14 |
2011-10-20 |
National Research Council Of Canada |
Compositions et méthodes utilisées pour l'administration en direction du cerveau de peptides analgésiques
|
WO2011153642A1
(fr)
|
2010-06-10 |
2011-12-15 |
Angiochem Inc. |
Conjugués et protéines de fusion de la leptine et d'analogues de la leptine et leur utilisation
|
RU2013103763A
(ru)
|
2010-07-02 |
2014-08-10 |
Ангиохем Инк. |
Короткие и содержащие d-аминокислоты полипептиды для терапевтических конъюгатов и их применения
|
US8218280B2
(en)
|
2010-07-08 |
2012-07-10 |
Schneider Electric USA, Inc. |
Secondary thermal sensor for primary conductors
|
US20120156130A1
(en)
|
2010-08-06 |
2012-06-21 |
Thore Hettmann |
Use of her3 binding agents in prostate treatment
|
CN102406949B
(zh)
|
2010-09-21 |
2013-05-29 |
复旦大学 |
一种靶向示踪的多模式诊断纳米影像药物
|
WO2012037687A1
(fr)
|
2010-09-23 |
2012-03-29 |
Angiochem Inc. |
Polypeptides thérapeutiques et leurs utilisations
|
US8901133B2
(en)
|
2010-11-10 |
2014-12-02 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
RU2018102375A
(ru)
|
2010-11-18 |
2019-02-21 |
Зе Дженерал Хоспитал Корпорейшен |
Новые композиции и применения антигипертензивных средств для терапии рака
|
CN102552928A
(zh)
|
2010-12-19 |
2012-07-11 |
复旦大学 |
一种治疗脑部肿瘤的双级靶向递药系统及其制备方法
|
PE20141303A1
(es)
|
2011-01-10 |
2014-10-01 |
Infinity Pharmaceuticals Inc |
Procedimiento para preparar isoquinolinonas y formas solidas de isoquinolinonas
|
CN102614105A
(zh)
|
2011-01-28 |
2012-08-01 |
复旦大学 |
一种脑靶向载两性霉素b聚合物胶束给药系统
|
EP2680820B1
(fr)
|
2011-03-01 |
2022-11-02 |
2-BBB Medicines B.V. |
Chargement liposomal actif avancé de substances médiocrement solubles dans l'eau
|
WO2012135025A2
(fr)
|
2011-03-28 |
2012-10-04 |
Massachusetts Institute Of Technology |
Lipomères conjugués et utilisations associées
|
US20140010886A1
(en)
|
2011-04-07 |
2014-01-09 |
Georgia Tech Research Corporation |
Compositions comprising saccharide binding moieties and methods for targeted therapy
|
JP2014518862A
(ja)
|
2011-05-09 |
2014-08-07 |
インスティトゥト・キミク・デ・サリア |
薬物送達用ポリマーナノ粒子
|
WO2013004716A1
(fr)
|
2011-07-04 |
2013-01-10 |
Universität Basel |
Billes à base de peptides
|
JP6027610B2
(ja)
|
2011-07-19 |
2016-11-16 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
複素環式化合物及びその使用
|
CA2842190A1
(fr)
|
2011-07-19 |
2013-01-24 |
Infinity Pharmaceuticals Inc. |
Composes heterocycliques et leurs utilisations
|
CN103957918A
(zh)
|
2011-08-11 |
2014-07-30 |
因特利凯有限责任公司 |
激酶抑制剂多晶型物
|
US8785470B2
(en)
|
2011-08-29 |
2014-07-22 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
WO2013049332A1
(fr)
|
2011-09-29 |
2013-04-04 |
Infinity Pharmaceuticals, Inc. |
Inhibiteurs de monoacylglycérol lipase et procédés de leur utilisation
|
WO2013056096A1
(fr)
|
2011-10-13 |
2013-04-18 |
Angiochem Inc. |
Conjugués polypeptides opioïdes et utilisations associées
|
MX363734B
(es)
|
2011-10-27 |
2019-03-29 |
Massachusetts Inst Technology |
Derivados de aminoacidos funcionalizados en la terminal n capaces de formar microesferas encapsuladoras de farmaco.
|
WO2013071272A1
(fr)
|
2011-11-11 |
2013-05-16 |
Intellikine, Llc |
Polymorphes d'inhibiteur de kinase
|
US20140335163A1
(en)
|
2011-12-01 |
2014-11-13 |
Angiochem Inc. |
Targeted iduronate-2-sulfatase compounds
|
MX2014006594A
(es)
|
2011-12-01 |
2015-09-16 |
Angiochem Inc |
Compuestos de enzimas lisosomales apuntados.
|
MX359410B
(es)
|
2011-12-13 |
2018-09-27 |
Engeneic Molecular Delivery Pty Ltd |
Minicélulas intactas derivadas bacterialmente para suministro de agentes terapéuticos a tumores cerebrales.
|
AU2012351967A1
(en)
|
2011-12-16 |
2014-07-17 |
Massachusetts Institute Of Technology |
Alpha-aminoamidine polymers and uses thereof
|
WO2013120107A1
(fr)
|
2012-02-09 |
2013-08-15 |
University Of Rochester |
Procédés et compositions pour traiter un sujet pour inhiber la perte auditive
|
EP2819686A4
(fr)
|
2012-03-02 |
2016-05-25 |
Icahn School Med Mount Sinai |
Variants de prothymosine alpha et leurs procédés d'utilisation
|
JP6042527B2
(ja)
|
2012-04-04 |
2016-12-14 |
ハロザイム インコーポレイテッド |
抗ヒアルロナン剤と腫瘍標的タキサンの組み合わせ治療
|
WO2013162757A1
(fr)
|
2012-04-26 |
2013-10-31 |
Yale University |
Molécule de délivrance de médicament sous forme cytotoxique ciblant le vih (cdm-h), activité cytotoxique contre le virus de l'immunodéficience humaine et leurs méthodes d'utilisation
|
JP2015521463A
(ja)
|
2012-06-15 |
2015-07-30 |
アンジオケム インコーポレーテッド |
標的化イズロニダーゼ化合物
|